Exploring marine resources for bioactive compounds

Planta Medica

Volumn 80, Issue 14, 2014, Pages 1234-1246

  Kiuru, Paula ^a   Valeria D'Auria M ^b   Muller, Christian D ^c   Tammela, Päivi ^a   Vuorela, Heikki ^a   Yli Kauhaluoma, Jari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

biodiversity; cyanobacteria; fungi; macroalgae; marine bioactive compounds; marine drug discovery; marine invertebrates; microalgae

Indexed keywords

BIOCIDE; BIOLOGICAL PRODUCT; BRENTUXIMAB VEDOTIN; COSMETIC; CYTARABINE; DEHYDRODIDEMNIN B; ELISIDEPSIN; ERIBULIN; HERBICIDE; NUTRACEUTICAL; OMEGA CONOTOXIN MVIIA; PHYTOHORMONE; TETRODOTOXIN; TRABECTEDIN;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ASCOMYCETES; BIODIVERSITY; BIOFILM; BIOLOGICAL ACTIVITY; BIOSENSOR; BIOTECHNOLOGICAL PRODUCTION; CHYTRIDIOMYCETES; COASTAL WATERS; CYANOBACTERIUM; DINOFLAGELLATE; ETHICS; FOOD PROCESSING; HUMAN; INFLAMMATION; ISOLATION AND PURIFICATION; MACROALGA; MARINE ENVIRONMENT; MARINE SPECIES; MASS SPECTROMETRY; MICROALGA; NEOPLASM; NONHUMAN; OOMYCETES; REVIEW; ANIMAL; AQUATIC SPECIES; BACTERIUM; CHEMISTRY; FISH; FUNGUS; INVERTEBRATE; SEAWEED;

CYANOBACTERIA; FUNGI; INVERTEBRATA;

ANIMALS; AQUATIC ORGANISMS; BACTERIA; BIODIVERSITY; BIOLOGICAL PRODUCTS; CYANOBACTERIA; FISHES; FUNGI; HUMANS; INVERTEBRATES; MICROALGAE; SEAWEED;

EID: 84928627815     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1383001     Document Type: Review

References (115)

1. Blunt J. W., Munro M. HG. Dictionary of marine natural products. Boca Raton Chapmann & Hall/CRC: 2007; (Available at http://dmnp.chemnetbase.com/intro/index.jsp. Accessed July 2, 2014.)
2. Mora C., Tittensor D. P., Adl S., Simpson A. GB, Worm B. How many species are there on Earth and in the ocean? PLoS Biol: 2011; 9 e1001127
3. Sennet S. H. Marine chemical ecology: applications in marine biomedical prospecting. In: McClintock J. B., Baker B. J. editors Marine chemical ecology. Boca Raton CRC Press: 2001; 523 542
4. Blunt J. W., Copp B. R., Keyzers R. A., Munro M. HG, Prinsep M. R. Marine natural products. Nat Prod Rep: 2014; 31 160 258
5. Blunt J. W., Copp B. R., Keyzers R. A., Munro M. HG, Prinsep M. R. Marine natural products. Nat Prod Rep: 2013; 30 237 323
6. Cragg G. M., Newman D. J. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta: 2013; 1830 3670 3695
7. Mayer A. M., Glaser K. B., Cuevas C., Jacobs R. S., Kem W., Little R. D., McIntosh J. M., Newman D. J., Potts B. C., Shuster D. E. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci: 2010; 31 255 265
8. Cuevas C., Pérez M., Martín M. J., Chicharro J. L., Fernández-Rivas C., Flores M., Francesch A., Gallego P., Zarzuelo M., de La Calle F., García J., Polanco C., Rodríguez I., Manzanares I. Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Org Lett: 2000; 2 2545 2548
9. Kem W., Soti F., Wildeboer K., LeFrancois S., MacDougall K., Wei D. Q., Chou K. C., Arias H. R. The nemertine toxin anabaseine and its derivative DMXBA (GTS-21): chemical and pharmacological properties. Mar Drugs: 2006; 4 255 273
10. Molinski T. F., Dalisay D. S., Lievens S. L., Saludes J. P. Drug development from marine natural products. Nat Rev Drug Discov: 2009; 8 69 85
11. Coll M., Carreras M., Ciercoles C., Cornax M. J., Gorelli G., Morote E., Saez R. Assessing fishing and marine biodiversity changes using fishers perceptions: the Spanish Mediterranean and Gulf of Cadiz case study. PLoS One: 2014; 9 e85670/1 e85670/15
12. Cragg G. M., Katz F., Newman D. J., Rosenthal J. Legal and ethical issues involving marine biodiscovery and development. In: Fattorusso E., Gerwick W. H., Taglialatela-Scafati O. editors Handbook of marine natural products. Dordrecht Springer: 2012; 1314 1342
13. Gareth R. J., Jennifer M. G. The experience and evolution of trust: implications for cooperation and teamwork. Acad Manage Rev: 1998; 23 531 546
14. Kornprobst J. M. Encyclopedia of marine natural products, Volume 1. Weinheim Wiley-Blackwell: 2010; 43 169 447
15. Rothschild L. J., Mancinelli R. L. Life in extreme environments. Nature: 2001; 409 1092 1101
16. Thomas T. RA, Kavlekar D. P., LokaBharathi P. A. Marine drugs from sponge-microbe association-A review. Mar Drugs: 2010; 8 1417 1468
17. Felczykowska A., Bloch S. K., Nejman-Faleńczyk B., Barańska S. Metagenomic approach in the investigation of new bioactive compounds in the marine environment. Acta Biochim Pol: 2012; 59 501 505
18. Butler M. S., Blaskovich M. A., Cooper M. A. Antibiotics in the clinical pipeline in 2013. J Antibiot: 2013; 66 571 591
19. Jang K. H., Nam S. J., Locke J. B., Kauffman C. A., Beatty D. S., Paul L. A., Fenical W. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angew Chem Int Ed: 2013; 52 7822 7824
20. Mahajan G., Thomas B., Parab R., Patel Z. E., Kuldharan S., Yemparala V., Mishra P. D., Ranadive P., DSouza L., Pari K., Girish H. S. In vitro and in vivo activities of antibiotic PM181104. Antimicrob Agents Chemother: 2013; 57 5315 5319
21. Singh S., Kate B. N., Banerjee U. C. Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol: 2005; 25 73 95
22. Burja A. M., Banaigs B., Abou-Mansourc E., Burgess J. G., Wright P. C. Marine cyanobacteria-a prolific source of natural products. Tetrahedron: 2001; 57 9347 9377
23. Welker M., von Döhren H. Cyanobacterial peptides - natures own combinatorial biosynthesis. FEMS Microbiol Rev: 2006; 30 530 563
24. Cohen Z., Margheri M. C., Tomaselli L. Chemotaxonomy of cyanobacteria. Phytochemistry: 1995; 40 1155 1158
25. Welker M., Brunke M., Preussel K., Lippert I., von Döhren H. Diversity and distribution of Microcystis (Cyanobacteria) oligopeptide chemotypes from natural communities studied by single-colony mass spectrometry. Microbiology: 2004; 150 1785 1796
26. Welker M., Christiansen G., von Döhren H. Diversity of coexisting Planktothrix (Cyanobacteria) chemotypes deduced by mass spectral analysis of microystins and other oligopeptides. Arch Microbiol: 2004; 182 288 298
27. Diehnelt C. W., Dugan N. R., Peterman S. M., Budde W. L. Identification of microcystin toxins from a strain of Microcystis aeruginosa by liquid chromatography introduction into a hybrid linear ion trap - Fourier transform ion cyclotron resonance mass spectrometer. Anal Chem: 2006; 78 501 512
28. Walker M., Erhard M. Consistency between chemotyping of single filaments of Planktothrix rubescens (Cyanobacteria) by MALDI-TOF and the peptide patterns of strains determined by HPLC-MS. J Mass Spectrom: 2007; 42 1062 1068
29. Shimizu Y. Microalgal metabolites. Chem Rev: 1993; 93 1685 1698
30. Daranas A. H., Norte M., Fernández J. J. Toxic marine microalgae. Toxicon: 2001; 39 1101 1132
31. Nicolaou K. C., Aversa R. J. Maitotoxin: an inspiration for synthesis. Isr J Chem: 2011; 51 359 377
32. Matsubara K. Recent advances in marine algal anticoagulants. Curr Med Chem Cardiovasc Hematol Agents: 2004; 2 13 19
33. Ekanayake P. M., Nikapitiya C., De Zoysa M., Whang I., Kim S. J., Lee J. Novel anticoagulant compound from fermented red alga Pachymeniopsis elliptica. Eur Food Res Technol: 2008; 227 897 903
34. Pushpamali W. A., Nikapitiya C., De Zoysa M., Whang I., Kim S. J., Lee J. Isolation and purification of an anticoagulant from fermented red seaweed Lomentaria catenata. Carbohydr Polym: 2008; 73 274 279
35. de Nys R., Steinberg P. D. Linking marine biology and biotechnology. Curr Opin Biotechnol: 2002; 13 244 248
36. Duarte K., Rocha-Santos T. AP, Freitas A. C., Duarte A. C. Analytical techniques for discovery of bioactive compounds from marine fungi. Trends Anal Chem: 2012; 34 97 110
37. Bergmann W., Feeney R. J. Contributions to the study of marine products. XXXII. The nucleosides of sponges I. J Org Chem: 1951; 16 981 987
38. Lemaire P. Evolutionary crossroads in developmental biology: the tunicates. Development: 2011; 138 2143 2152
39. Lewis R. J., Garcia M. L. Therapeutic potential of venom peptides. Nat Rev Drug Discov: 2003; 2 790 802
40. Clark R. J., Jensen J., Nevin S. T., Callaghan B. P., Adams D. J., Craik D. J. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed: 2010; 49 6545 6548
41. Rocha J., Peixe L., Gomes N. CM, Calado R. Cnidarians as a source of new marine bioactive compounds-an overview of the last decade and future steps for bioprospecting. Mar Drugs: 2011; 9 1860 1886
42. Mackie G. O. Whats new in cnidarian biology? Can J Zool: 2002; 80 1649 1653
43. Nelson J. S. Fishes of the world, 4th edition. Hoboken John Wiley & Sons Inc: 2006; 2 5
44. Reddy L. H., Couvreur P. Squalene: a natural triterpene for use in disease management and therapy. Adv Drug Deliv Rev: 2009; 61 1412 1426
45. Nieto F. R., Cobos E. J., Tejada M. Á, Sánchez-Fernández C., González-Cano R., Cendán C. R. Tetrodotoxin (TTX) as a therapeutic agent for pain. Mar Drugs: 2012; 10 281 305
46. Esteves-Ferreira A. A., Correa D. M., Carneiro A. PS, Rosa R. M., Loterio R., Araujo W. L. Comparative evaluation of different preservation methods for cyanobacterial strains. J Appl Phycol: 2013; 25 919 929
47. Guillard R. RL. Purification methods for microalgae. In: Andersen A. R. editor Algal culturing techniques. China Elsevier Academic Press: 2005; 117 132
48. Bohlin L., Alsmark C., Goeransson U., Klum M., Weden C., Backlund A. In: Tringali C, editor. Bioactive compounds from natural sources. 2nd edition. Boca Raton CRC Press: 2012; 1 36
49. Eriksen N. T. The technology of microalgal culturing. Biotechnol Lett: 2008; 30 1525 1536
50. Schmidt R. S. Heterotrophic high cell-density fed-batch cultures of the phycocyanin-producing red alga Galdieria sulphuraria. Biotechnol Bioengin: 2005; 90 77 84
51. Kupchan S. M., Britton R. W., Ziegler M. F., Sigel C. W. Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica. J Org Chem: 1973; 38 178 179
52. Donia M. S., Ruffner D. E., Cao S., Schmidt E. W. Accessing the hidden majority of marine natural products through metagenomics. Chembiochem: 2011; 12 1230 1236
53. Breton R. C., Reynolds W. F. Using NMR to identify and characterize natural products. Nat Prod Rep: 2013; 30 501 524
54. Ghitti M., Musco G., Spitaleri A. NMR and computational methods in the structural and dynamic characterization of ligand-receptor interactions. Adv Exp Med Biol: 2014; 805 271 304
55. Matsumori N., Kaneno D., Murata M., Nakamura H., Tachibana K. Stereochemical determination of acyclic structures based on carbon-proton spin-coupling constants. A method of configuration analysis for natural products. J Org Chem: 1999; 64 866 876
56. Seco J. M., Quiñoá E., Riguera R. The assignment of absolute configuration by NMR. Chem Rev: 2004; 104 17 117
57. Lee J. A., Berg E. L. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches. J Biomol Screen: 2013; 18 1143 1155
58. Fishburn C. S. Translational research: the changing landscape of drug discovery. Drug Discov Today: 2013; 18 487 494
59. Lang P. K., Yeow K., Nichols A., Sheer A. Cellular imaging in drug discovery. Nat Rev Drug Discov: 2006; 5 343 356
60. Lee J. A., Uhlik M. T., Moxham C. M., Tomandl D., Sall D. J. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. J Med Chem: 2012; 55 4527 4538
61. Sams-Dodd F. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift. Drug Discov Today: 2013; 18 211 217
62. Harvey A. L. Natural products as a screening resource. Curr Opin Chem Biol: 2007; 11 480 484
63. Bugni T. S., Richards B., Bhoite L., Cimbora D., Harper M. K., Ireland C. M. Marine natural product libraries for high-throughput screening and rapid drug discovery. J Nat Prod: 2008; 71 1095 1098
64. Tawfike A. F., Viegelmann C., Edrada-Ebel R. Metabolomics and dereplication strategies in natural products. Methods Mol Biol: 2013; 1055 227 244
65. Larsen T. O., Smedsgaard J., Nielsen K. F., Hansen M. E., Frisvad J. C. Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Nat Prod Rep: 2005; 22 672 695
66. Koehn F. E., Carter G. T. The evolving role of natural products in drug discovery. Nat Rev Drug Discov: 2005; 4 206 220
67. Florence G. J., Gardner N. M., Ian Paterson I. Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin. Nat Prod Rep: 2008; 25 342 375
68. Chen J. C., Chen X. C., Willot M., Zhu J. Asymmetric total syntheses of ecteinascidin 597 and ecteinascidin 583. Angew Chem Int Ed: 2006; 45 8028 8032
69. Shang S., Tan D. S. Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries. Curr Opin Chem Biol: 2005; 9 248 258
70. Mantovani A., Balkwill F. RalB signaling: a bridge between inflammation and cancer. Cell: 2006; 127 42 44
71. Castellani P., Balza E., Rubartelli A. Inflammation, DAMPs, tumor development, and progression: a vicious circle orchestrated by redox signaling. Antioxid Redox Sign: 2014; 20 1086 1097
72. Luo J. L., Kamata H., Karin M. IKK/NF- κ B signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest: 2005; 115 2625 2632
73. Luo J. L., Maeda S., Hsu L. C., Yagita H., Karin M. Inhibition of NF- κ B in cancer cells converts inflammation- induced tumor growth mediated by TNF α to TRAIL-mediated tumor regression. Cancer Cell: 2004; 3 297 305
74. Karin M., Greten F. R. NF- κ B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol: 2005; 10 749 759
75. Grienke U., Silke J., Tasdemir D. Bioactive compounds from marine mussels and their effects on human health. Food Chemistry: 2014; 142 48 60
76. Kim J. A., Kim S. K. Bioactive peptides from marine sources as potential anti-inflammatory therapeutics. Curr Protein Pept Sci: 2013; 14 177 182
77. Moczydlowski E. G. The molecular mystique of tetrodotoxin. Toxicon: 2013; 63 165 183
78. Greenberg E. N. Ziconitide. J Pain Palliat Care Pharmacother: 2011; 25 380 381
79. Adams D. J., Berecki G. Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels. Biochim Biophys Acta: 2013; 1828 1619 1628
80. Kresse H., Belsey M. J., Rovin H. The antibacterial drugs market. Nat Rev Drug Discov: 2007; 6 19 20
81. Weaver S. C., Barrett A. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol: 2004; 2 789 801
82. Pialoux G., Gaüzère B. A., Jauréguiberry S., Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis: 2007; 7 319 327
83. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A. C., Panning M., Cordioli P., Fortuna C., Boros S., Magurano F., Silvi G., Angelini P., Dottori M., Ciufolini M. G., Majori G. C., Cassone A. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet: 2007; 370 1840 1846
84. Brummer-Korvenkontio M., Vapalahti O., Kuusisto P., Saikku P., Manni T., Koskela P., Nygren T., Brummer-Korvenkontio H., Vaheri A. Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern. Epidemiol Infect: 2002; 129 335 345
85. Mayer A. MS, Jacobson P. B., Fenical W., Jacobs R. S., Glaser K. B. Pharmacological characterization of the pseudopterosins: novel anti-inflammatory natural products isolated from the Caribbean soft coral, Pseudopterogorgia elisabethae. Life Sci: 1998; 62 PL401 PL407
86. Castanaro J., Lasker H. R. Effects of clipping on growth of colonies of the Caribbean gorgonian Pseudopterogorgia elisabethae. Invertebr Biol: 2003; 122 299 307
87. Moore A. Blooming prospects? Humans have eaten seaweed for millennia; now microalgae are to be served up in a variety of novel health supplements, medicaments and preparations. EMBO Rep: 2001; 2 462 464
88. Zhu D., Niu J., Shen S., Wang G. An economic assessment of astaxanthin production by large scale cultivation of Haematococcus pluvialis. Biotechn Adv: 2011; 29 568 574
89. Picot C., Nguyen T. A., Roudot A. C., Parent-Massin D. A. Preliminary risk assessment of human exposure to phycotoxins in shellfish: a review. Hum Ecol Risk Assess: 2011; 17 328 366
90. Vilarino N., Louzao M. C., Fraga M., Rodriguez L. P., Botana L. M. Innovative detection methods for aquatic algal toxins and their presence in the food chain. Anal Bioanal Chem: 2013; 405 7719 7732
91. Campbell K. Biosensor technology for marine toxin analysis. In: Botana L. M. editor Seafood and freshwater toxins, pharmacology, physiology, and detection. 3rd edition. Boca Raton CRC Press: 2014; 347 366
92. Eggins B. R. Chemical sensors and biosensors. New York John Wiley & Sons Inc: 2002; 5 9
93. Huang P. JJ, Khimji I., Liu J. Immobilization of fluorescent aptamer biosensors on magnetic microparticles and its potential application for ocean sensing. In: Tiquia-Arashiro S. M. editor Molecular biological technologies for ocean sensing. Dearborn Humana Press: 2012; 151 168
94. Weigl B. H., Bardell R. L., Cabrera C. R. Lab-on-a-chip for drug development. Adv Drug Deliv Rev: 2003; 55 349 377
95. Erickson D., Li D. Integrated microfluidic devices. Anal Chim Acta: 2004; 507 11 26
96. Marquette C. A., Coulet P. R., Blum L. J. Semi-automated membrane based chemiluminescent immunosensor for flow injection analysis of okadaic acid in mussels. Anal Chim Acta: 1999; 398 173 182
97. Desmet C., Blum L. J., Marquette C. A. Multiplex microarray ELISA versus classical ELISA, a comparison study of pollutant sensing for environmental analysis. Environ Sci Process Impacts: 2013; 15 1876 1882
98. Yakes B. J., Prezioso S. M., DeGrasse S. L. Developing improved immunoassays for paralytic shellfish toxins: the need for multiple, superior antibodies. Talanta: 2012; 99 668 676
99. Kulagina N. V., Twiner M. J., Hess P., McMahon T., Satake M., Yasumoto T., Ramsdell J. S., Doucette G. J., Ma W., OShaughnessy T. J. Detection of marine toxins, brevetoxin-3 and saxitoxin, in seawater using neuronal networks. Environ Sci Technol: 2006; 40 578 583
100. Strik W. A., Ördög V., Van Staden J., Jäger K. Cytokinin- and auxin-like activity in Cyanophyta and microalgae. J Appl Phycol: 2002; 14 215 221
101. Karthikeyan N., Prasanna R., Nain L., Kaushik B. D. Evaluating the potential of plant growth promoting cyanobacteria as inoculants for wheat. Eur J Soil Biol: 2007; 43 23 30
102. Peuthert A., Chakrabarti S., Pflugmache S. Uptake of microcystins-LR and -LF (cyanobacterial toxins) in seedlings of several important agricultural plant species and the correlation with cellular damage (lipid peroxidation). Environ Toxicol: 2007; 22 436 442
103. Zaccaro M. C., Kato A., Zulpa G., Storni M. M., Steyerthal N., Lobasso K., Stella A. M. Bioactivity of Scytonema hofmanni (Cyanobacteria) in Lilium alexandrae in vitro propagation. Electr J Biotechnol: 2006; 9 210 214
104. Berry J. P., Gantar M., Perez M. H., Berry G., Noriega F. G. Cyanobacterial toxins as allelochemicals with potential applications as algaecides, herbicides and insecticides. Mar Drugs: 2008; 6 117 146
105. Hellio C., Tsoukatou M., Maréchal J. P., Aldred N., Beaupoil C., Clare A. S., Vagias C., Roussis V. Inhibitory effects of Mediterranean sponge extracts and metabolites on larval settlement of the barnacle Balanus amphitrite. Mar Biotechnol: 2005; 7 297 305
106. Chelossi E., Mancini I., Sepčić K., Turk T., Faimali M. Comparative antibacterial activity of polymeric 3-alkylpyridinium salts isolated from the Mediterranean sponge Reniera sarai and their synthetic analogues. Biomol Engin: 2006; 23 317 323
107. Sjoegren M., Johnson A. L., Hedner E., Dahlstroem M., Goeransson U., Shirani H., Bergman J., Jonsson P. R., Bohlin L. Antifouling activity of synthesized peptide analogs of the sponge metabolite barettin. Peptides: 2006; 27 2058 2064
108. Sjoegren M., Dahlstroem M., Goeransson U., Jonsson P., Bohlin L. Recruitment in the field of Balanus improvisus and Mytilus edulis in response to the antifouling cyclopeptides barettin and 8,9-dihydrobarettin from the marine sponge Geodia barrette. Biofouling: 2004; 20 291 297
109. Hall-Stoodley L., Costerton J. W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nature Rev Microbiol: 2004; 2 95 108
110. Lear G., Lewis G. D. Microbial biofilms: current research and applications. Norfolk Caister Academic Press: 2012; 1 228
111. Matz C., Webb J. S., Schupp P. J., Phang S. Y., Penesyan A., Egan S., Steinberg P., Kjelleberg S. Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS One: 2008; 3 1 7
112. Matz C. Struggle, communication, cooperation. Biochemical interactions in marine biofilms. Chem Unserer Zeit: 2009; 43 160 167
113. Skogman M., Vuorela P., Fallarero A. Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms. J Antibiot: 2012; 65 453 459
114. Manner S., Skogman M., Goeres D., Vuorela P., Fallarero A. Systematic exploration of natural and synthetic flavonoids for inhibition of Staphylococcus aureus biofilms. Int J Mol Sci: 2013; 14 19434 19451
115. Ausbacher D., Fallarero A., Määttänen A., Kujala J., Ström M. B., Vuorela P. M. Staphylococcus aureus biofilm susceptibility to small and potent β 2,2-amino acid derivatives. Biofouling: 2014; 30 81 93